medigraphic.com
ISSN 1405-1699 (Print)
Órgano Oficial del Colegio Mexicano de Alergia, Asma e Inmunología Pediátrica y de la Asociación Latinoamericana de Pediatría

2000, Number 2

<< Back

Alerg Asma Inmunol Pediatr 2000; 9 (2)

Rush immunotherapy

Bermudes UCH

Language: Spanish
References: 9
Page: 69
PDF size: 283.74 Kb.


ABSTRACT

The immunotherapy is an effective treatment for allergic illnesses. Their administration consists traditionally on the weekly application of a small quantity of extract of some allergen, with slow increment of the dose until reaching the dose of maintenance or therapeutic dose. The necessary good effective dose, it should be immunogenic and ideally it should not induce a systemic reaction. The traditional outline consists on an or two applications a week, until reaching the dose of maintenance in 4 to 6 weeks. The rush immunotherapy consists on a series of quick injections of allergenics extracts that arrive in a quick increment of the dosis of allergens that makes possible to reach the dose of maintenance in a short time.


REFERENCES

  1. Shardey P, Portnoy J. Rush immunotherapy: experience with a one-day schedule. Ann Allergy Asthma Immunol 1996; 76: 175-80.

  2. Lack G, Nelson HS, Amran D, Oshiba A, Jung T, Bradley KL, Giclas PC, Gelfand EW. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferón-g production in CD4+ T cells. J Allergy Clin Immunol 1997; 99: 530-8.

  3. Greenberger PA. Rush injection therapy for asthma and allergic rhinitis, Guest editorial. Annals of Allergy 1994; 73: 378-380.

  4. Oppenheimer JJ, Nelson HS, Bock SA, Christensen F, BSN MA, Leung DYM. Treatment of peanut allergy with rush immunotherapy. J Allergy Clin Immunol 1992; 90: 256-62.

  5. Kohno Y, Minoguchi K, Oda N, Yokoe T, Yamashita N, Sakane T, Adachi M. Effect of rush immunotherapy on airway inflammation and airway hyperresponsiveness after bronchoprovocation with allergen in asthma. J Allergy Clin Immunol 1998; 102: 927-34.

  6. Lower T, Henry J, Mandek I, Janosky J, Friday GA Jr. Compliance with allergen immunotherapy. Annals of Allergy 1993; 70: 480-2.

  7. Nagata M, Yamamoto H, Kimura TT, Houya I, Kuramitsu K. Effect of rush immunotherapy in house-dust-mite (HDM) sensitive adult bronchial asthma: changes in vivo and in vitro responses to HDM. Intern Med 1993; 32: 702-9.

  8. Peng Z, Naclerio RM, Norman PS, Adkinson NF Jr. Quantitative IgE and IgG subclases responses during and after long-term ragweed immunotherapy. J Allergy Clin Immunol 1992; 89: 519-29.

  9. Rak S, Lawhagen O, Venge P. The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic proteinin pollen-allergic patients. J Allergy Clin Immunol 1988; 82: 470-80.




2020     |     www.medigraphic.com